Lahore City
Lahore, Pakistan
NCT Number: NCT07055711
This research aims to find the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.
This study is active but is not currently recruiting participants.
21 year–51 year
Female
Observational
Lahore, Pakistan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
to find out the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.
Time frame: 6 Month
The DN4 questionnaire is used to assess the neuropathic pain, if the score is > 4 it indicates the neuropathic pain is present while <3 than is unlikely.
Time frame: 6 Months
The visual analog scale provide quantitative measurement of pain level which is from no pain to severe pain . The range of the scale is in between 0-10mm. 0-4 is consider as no pain, 5-44 is consider as mild pain,45-74 is moderate and > 75 is consider as severe pain.
Superior University
Other
Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Survivors Post-Chemotherapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07674420
Cardiovascular Diseases, Diabetes
Baltimore, Maryland, United States
View Trial DetailsNCT05357469
Nervous System Diseases, Neuromuscular Diseases
Houston, Texas, United States
View Trial DetailsNCT06151600
Nervous System Diseases, Neuro-Degenerative Disease
San Francisco, California, United States
View Trial DetailsNCT03584022
Amyloidosis, Autoimmune Diseases
Rochester, Minnesota, United States
View Trial Details